Journal of Endocrinological Investigation

, Volume 24, Issue 5, pp 370–383 | Cite as

Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes

Review Article

Abstract

The list of multiple endocrine neoplasias (MENs) that have been molecularly elucidated is growing with the most recent addition of Carney complex. MEN type 1 (MEN 1), which affects primarily the pituitary, pancreas, and parathyroid glands, is caused by mutations in the menin gene. MEN type 2 (MEN 2) syndromes, MEN 2A and MEN 2B that affect mainly the thyroid and parathyroid glands and the adrenal medulla, and familial medullary thyroid carcinoma (FMTC), are caused by mutations in the RET oncogene. Finally, Carney complex, which affects the adrenal cortex, the pituitary and thyroid glands, and the gonads, is caused by mutations in the gene that codes for regulatory subunit type 1A of protein kinase A (PKA) (PRKAR1A) in at least half of the known patients. Molecular defects have also been identified in syndromes related to the MENs, like Peutz-Jeghers syndrome (PJS) (the STK11/LKB1 gene), and Cowden (CD; the PTEN gene) and von Hippel-Lindau disease (VHLD; the VHL gene). Although recognition of these syndromes at a young age generally improves prognosis, the need for molecular testing in the diagnostic evaluation of the MENs is less clear. This review presents the newest information on the clinical and molecular genetics of the MENs (MEN 1, MEN 2, and Carney complex), including recommendations for genetic screening, and discusses briefly the related syndromes PJS, CD and VHLD.

Key-words

Multiple endocrine neoplasia syndromes Carney complex Peutz-Jeghers syndrome Cowden disease protein kinase A 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am. J. Med. 1954, 16: 363–371.PubMedCrossRefGoogle Scholar
  2. 2.
    Sipple J.H. The association of pheochromocytomas with carcinoma of the thyroid gland. Am. J. Med. 1961, 31: 163–166.CrossRefGoogle Scholar
  3. 3.
    Eng C. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung’s disease. N. Engl. J. Med. 1996, 335: 943–951.PubMedCrossRefGoogle Scholar
  4. 4.
    Carney J.A., Gordon H., Carpenter P.C., Shenoy B.V., Go V.L.W. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985, 64: 270–283.CrossRefGoogle Scholar
  5. 5.
    Mulligan L.M., Kwok J.B.J., Healey C.S., Elsdon M.J., Eng C., Gardner E., Love D.R., Mole S.E., Moore J.K., Papi L., Ponder M.A., Telenius H., Tunnacliffe A., Ponder B.A.J. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993, 363: 458–460.PubMedCrossRefGoogle Scholar
  6. 6.
    Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S.E., Collins F.S., Emmert-Buck M.R., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Crabtree J.S., Wang Y., Roe B.A., Weisemann J., Boguski M.S., Agarwal S.K., Kester M.B., Kim Y.S., Heppner C., Dong Q., Spiegel A.M., Burns A.L., Marx S.J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997, 276: 404–407.PubMedCrossRefGoogle Scholar
  7. 7.
    Kirschner L.S., Carney J.A., Pack S., Taymans S.E., Cho Y.S., Cho-Chung Y., Stratakis C.A. Mutations in the gene encoding the type Ia regulatory subunit of the protein kinase A (PRKARIA) in patients with Carney complex. Nat. Genet. 2000, 26: 89–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., Bignell G., Warren W., Aminoff M., Hoglund P., Jarvinen H., Kristo P., Pelin K., Ridanpaa M., Salovaara R., Toro T., Bodmer W., Olschwang S., Olsen A.S., Stratton M.R., de la Chapelle A., Aaltonen L.A. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998, 391: 184–187.PubMedCrossRefGoogle Scholar
  9. 9.
    Jenne D.E., Reimann H., Nezu J., Friedel W., Loff S., Jeschke R., Muller O., Back W., Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 1998, 18: 38–43.PubMedCrossRefGoogle Scholar
  10. 10.
    Liaw D., Marsh D.J., Li J., Dahia P.L., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., Eng C., Parsons R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 1997, 16: 64–67.PubMedCrossRefGoogle Scholar
  11. 11.
    Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L., Stackhouse T., Kuzmin I., Modi W., Geil L., Schmidt L., Zhou F., Li H., Wei M.H., Chen F., Glenn G., Choyke P., McClellan M.W., Weng Y., Duan D.-S.R., Dean M., Glavac D., Richards F.M., Crossey P.A., Ferguson-Smith M.A., Le Paslier D., Chumakov I., Cohen D., Chinault A.C., Maher E.R., Linean W.M., Zbar B., Lerman M.I. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260: 1317–1320.PubMedCrossRefGoogle Scholar
  12. 12.
    Gagel R.F., Jackson C.E., Ponder B.A.J., Raue F., Simpson N.E., Ziegler R. Multiple endocrine neoplasia type 2 syndromes: Nomenclature recommendations from the workshop organizing committee. Henry Ford Hosp. Med. J. 1989, 37: 99.Google Scholar
  13. 13.
    Online Mendelian Inheritance in Man, OMIM (TM). Center for Medical Genetics, Johns Hopkins University, and National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, 1999, World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim Google Scholar
  14. 14.
    Marx S.J., Agarwal S.K., Kester M.B., Heppner C., Kim Y.S., Skarulis M.C., James L.A., Goldsmith P.K., Saggar S.K., Park S.Y., Spiegel A.M., Burns A.L., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Emmert-Buck M.R., Guru S.C., Manickam P., Crabtree J., Erdos M.R., Collins F.S., Chandrasekharappa S.C. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent. Prog. Horm. Res. 1999, 54: 397–438.PubMedGoogle Scholar
  15. 15.
    Marx S.J. Multiple endocrine neoplasia type 1. In: Bilezikian J.P., Levine M.A., Marcus R. (Eds.), The parathyroids. Raven Press. Ltd., New York, 2000, in press.Google Scholar
  16. 16.
    Trump D., Farren B., Wooding C., Pang J.T., Besser G.M., Buchanan K.D., Edwards C.R., Eath D.A., Jackson C.E., Jansen C.E., Lips K., Monson J.P., O’Halloran D., Sampson J., Shalet S., Wheeler M.H., Zink A., Thakker R. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q. J. Med. 1996, 89: 653–669.CrossRefGoogle Scholar
  17. 17.
    Vasen H.F., Lamers C.B., Lips C.J. Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands. Arch. Intern. Med. 1989, 149: 2717–2722.PubMedCrossRefGoogle Scholar
  18. 18.
    Skarulis M.C., Marx S., Spiegel A. M., Skarulis M.C., Doppman J.L., Collins F.S., Liotta L.A. Multiple endocrine neoplasia type 1: Clinical and genetic topics. Ann. Intern. Med. 1998, 129: 484–494.PubMedCrossRefGoogle Scholar
  19. 19.
    Lamers C.B., Froeling P.G. Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I). Am. J. Med. 1979, 66: 422–424.PubMedCrossRefGoogle Scholar
  20. 20.
    Marx S.J., Vinik A.I., Santen R.J., Floyd J.C. Jr., Mills J.L., Green J.D. Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred. Medicine (Baltimore) 1986, 65: 226–241.CrossRefGoogle Scholar
  21. 21.
    Ballard H.S., Frame B., Hartsock R.J. Familial multiple endocrine adenoma-peptic ulcer complex. Medicine 1964, 43: 481–516.PubMedCrossRefGoogle Scholar
  22. 22.
    Betts J.B., O’Malley B.P., Rosenthal F.D. Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1 — Report of a further family and a review of the literature. Q. J. Med. 1980, 49: 69–76.PubMedGoogle Scholar
  23. 23.
    Scheithauer B.W., Laws E.R. Jr., Kovacs K., Horvath E., Randall R.V., Carney J.A. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin. Diagn. Pathol. 1987, 4: 205–211.PubMedGoogle Scholar
  24. 24.
    Shepherd J.J. The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized? Arch. Surg. 1991, 126: 935–952.PubMedCrossRefGoogle Scholar
  25. 25.
    O’Brien T., O’Riordan D.S., Gharib H., Scheithauer B.W., Ebersold M.J., van Heerden J.A. Results of treatment of pituitary disease in multiple endocrine neoplasia, type I. Neurosurgery 1996, 39: 273–278; discussion 278–279.PubMedCrossRefGoogle Scholar
  26. 26.
    Stratakis C.A., Schussheim D.H., Freedman S.M., Keil M.F., Pack S.D., Agarwal S.M., Skarulis M.C., Weil R.J., Lubensky I.A., Zhuang Z., Oldfield E.H., Marx S.J. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type-1. J. Clin. Endocrinol. Metab. 2000, 85: 4920–4924.PubMedCrossRefGoogle Scholar
  27. 27.
    Giraud S., Zhang C.X., Serova-Sinilnikova O., Wautot V., Salandre J., Buisson N., Waterlot C., Bauters C., Porchet N., Aubert J.-P., Emy P., Cadiot G., Delemer B., Chabre O., Niccoli P., Leprat F., Duron F., Emperauger B., Cougard P., Coudet P., Sarfati E., Riou J.-P., Guihard S., Rodier M., Meyrier A., Caron P., Vantyghem M.-C., Assayag M., Peix J.-L., Pugeat M., Rohmer V., Vallotton M., Lenoir G., Gaudray P., Proye C., Conte-Devolx B., Chanson P., Shugart Y.Y., Goldgar D., Murat A., Calender A. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am. J. Hum. Genet. 1997, 63: 455–467.CrossRefGoogle Scholar
  28. 28.
    Thakker R.V. Multiple endocrine neoplasia-syndromes of the twentieth century. J. Clin. Endocrinol. Metab. 1998, 83: 2617–2620.PubMedGoogle Scholar
  29. 29.
    Gagel R.F. RET protooncogene mutations and endocrine neoplasia — A story intertwined with neural crest differentiation. Endocrinology 1996, 137: 1509–1511.PubMedGoogle Scholar
  30. 30.
    Eng C., Clayton D., Schuffenecker I., Lenoir G., Cote G., Gagel R.F., van Amstel H.K., Lips C.J., Nishisho I., Takai S.I., Marsh D.J., Robinson B.G., Frank-Raue K., Raue F., Xue F., Noll W.W., Romei C., Pacini F., Fink M., Niederle B., Zedenius J., Nordenskjold M., Komminoth P., Hendy G.N., Mulligan L.M. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996, 276: 1575–1579.PubMedCrossRefGoogle Scholar
  31. 31.
    Edery P., Eng C., Munnich A., Lyonnet S. RET in human development and oncogenesis. Bioessays 1997, 19: 389–395.PubMedCrossRefGoogle Scholar
  32. 32.
    Gagel R.F., Levy M.L., Donovan D.T., Alford B.R., Wheeler T., Tchen J.A. Multiple endocrine neoplasia type 2A associated with cutaneous lichen amyloidosis. Ann. Intern. Med. 1989, 111: 802–806.PubMedCrossRefGoogle Scholar
  33. 33.
    Borrego S., Eng C., Sanchez B., Saez M.E., Navarro E., Antinolo G. Molecular analysis of the RET and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease. Clin. Endocrinol. Metab. 1998, 83: 3361–3364.Google Scholar
  34. 34.
    Eng C., Mulligan L.M. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease. Hum. Mutat. 1997, 9: 97–109.PubMedCrossRefGoogle Scholar
  35. 35.
    Hoff A.O., Cote J., Gagel R.F. Multiple endocrine neoplasias. Annu. Rev. Physiol. 2000, 62: 377–411.PubMedCrossRefGoogle Scholar
  36. 36.
    Angrist M., Bolk S., Hallushka M., Lapchak P.A., Chakravarti A. Germline mutations in glial-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat. Genet. 1996, 14: 341–344.PubMedCrossRefGoogle Scholar
  37. 37.
    Decker R.A., Peacock M.L., Watson P. Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation. Hum. Mol. Genet. 1998, 7: 129–134.PubMedCrossRefGoogle Scholar
  38. 38.
    Stratakis C.A. Genetics of Carney complex and related familial lentiginoses, and other multiple tumor syndromes. Frontiers Biosc. 2000, 5: d353–366.CrossRefGoogle Scholar
  39. 39.
    Salomon F., Froesh E.R., Hedinger C.E. Familial Cushing syndrome (Carney complex). N. Engl. J. Med. 1990, 322: 1470.CrossRefGoogle Scholar
  40. 40.
    Shenoy B.V., Carpenter P.C., Carney J.A. Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am. J. Surg. Pathol. 1984, 8: 335–344.PubMedCrossRefGoogle Scholar
  41. 41.
    Schweizer-Cagianut M., Froesch E.R., Hedinger C.E. Familial Cushing’s syndrome with primary adrenocortical microadenomatosis (primary adrenocortical nodular dysplasia). Acta Endocrinol. (Copenh.) 1980, 94: 529–535.Google Scholar
  42. 42.
    Carney J.A., Hruska L.S., Beauchamp G.D., Gordon H. Dominant inheritance of the complex of myxomas, spotty pigmentation and endocrine overactivity. Mayo Clin. Proc. 1986, 61: 165–172.PubMedCrossRefGoogle Scholar
  43. 43.
    Carney J.A., Young W.F. Primary pigmented nodular adrenocortical disease and its associated conditions. Endocrinologist 1992, 2: 6–21.CrossRefGoogle Scholar
  44. 44.
    Atherton D.J., Pitcher D.W., Wells R.S., Macdonald D.M. A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome. Br. J. Dermatol. 1980, 103: 421–429.PubMedCrossRefGoogle Scholar
  45. 45.
    Rhodes A.R., Silverman R.A., Harrist T.J., Perez-Atayde A.R. Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: The “LAMB” syndrome. J. Am. Acad. Dermatol. 1984, 10: 72–82.PubMedCrossRefGoogle Scholar
  46. 46.
    Carney J.A. Differences between nonfamilial and familial cardiac myxoma. Am. J. Surg. Pathol. 1985, 9: 53–55.PubMedCrossRefGoogle Scholar
  47. 47.
    Kennedy R.H., Flanagan J.C., Eagle R.C. Jr., Carney J.A. The Carney complex with ocular signs suggestive of cardiac myxoma. Am. J. Ophthalmol. 1991, 111: 699–702.PubMedGoogle Scholar
  48. 48.
    Ferreiro J.A., Carney J.A. Myxomas of the external ear and their significance. Am. J. Surg. Pathol. 1994, 18: 274–280.PubMedCrossRefGoogle Scholar
  49. 49.
    Carney J.A., Toorkey B.C. Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas. Am. J. Surg. Pathol. 1991, 15: 713–721.PubMedCrossRefGoogle Scholar
  50. 50.
    Courcoutsakis N.A., Chow C.K., Shawker T., Carney J.A., Stratakis C.A. Breast imaging findings in the complex of myxomas, spotty pigmentation, endocrine veractivity, and schwannomas (Carney complex). Radiology 1997, 205: 221–227.PubMedGoogle Scholar
  51. 51.
    Carney J.A., Ferreiro J.A. The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am. J. Surg. Pathol. 1996, 20: 259–272.PubMedCrossRefGoogle Scholar
  52. 52.
    Carney J.A. Carney complex: the complex of myxomas, spotty pigmentation, endocrine veractivity, and schwannomas. Semin. Dermatol. 1995, 14: 90–98.PubMedCrossRefGoogle Scholar
  53. 53.
    Doppman J.L., Travis W.D., Nieman L., Miller D.L., Chrousos G.P., Gomez T.M., Loriaux D.L. Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology 1989, 172: 415–420.PubMedGoogle Scholar
  54. 54.
    Mellinger R.C., Smith R.W. Studies of the adrenal hyperfunction in 2 patients with atypical Cushing’s syndrome. J. Clin. Endocrinol. Metab. 1955, 16: 350–366.CrossRefGoogle Scholar
  55. 55.
    Kracht J., Tamm J. Bilaterale kleiknotige Adenomatose der Nebennierenrinde bei Cushing-Syndrom. Virchows Arch. Path. Anat. 1960, 333: 1–9.CrossRefGoogle Scholar
  56. 56.
    Levin M.E. The development of bilateral adenomatous adrenal hyperplasia in a case of Cushing’s syndrome of eighteen years’ duration. Am. J. Med. 1966, 40: 318–324.PubMedCrossRefGoogle Scholar
  57. 57.
    De Moor P., Roels H., Delaere K., Crabbe J. Unusual case of adrenocortical hyperfunction. J. Clin. Endocrinol. Metab. 1965, 25: 612–620.CrossRefGoogle Scholar
  58. 58.
    Sarlis N.J., Chrousos G.P., Doppman J.L., Carney J.A., Stratakis C.A. Primary pigmented nodular adrenocortical disease (PPNAD): re-evaluation of a patient with Carney complex 27 years after unilateral adrenalectomy. J. Clin. Endocrinol. Metab. 1997, 82: 2037–2043.CrossRefGoogle Scholar
  59. 59.
    Gomez-Muguruza M.T., Chrousos G.P. Periodic Cushing’s syndrome in a short boy: usefulness of the ovine corticotropin releasing hormone test. J. Pediatr. 1989, 115: 270–273.PubMedCrossRefGoogle Scholar
  60. 60.
    Stratakis C.A., Sarlis N.J., Kirschner L.S., Carney J.A., Doppman J.L., Chrousos G.P., Papanicolaou D.A. Paradoxical response to dexamethasone assists with the diagnosis of primary pigmented nodular adrenocortical disease (PPNAD). Ann. Intern. Med 1999, 131: 585–591.PubMedCrossRefGoogle Scholar
  61. 61.
    Watson J.C., Stratakis C.A., Bryant-Greenwood P.K., Koch C.A., Kirschner L.S., Nguyen T., Carney J.A., Oldfield E.H. Neurosurgical implications of Carney complex. J. Neurosurg. 2000, 92: 413–418.PubMedCrossRefGoogle Scholar
  62. 62.
    Raff S.B., Carney J.A., Krugman D., Doppman J.L., Stratakis C.A. Prolactin secretion abnormalities in patients with the “syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas” (Carney complex). J. Pediatr. Endocrinol. Metab. 2000, 13: 373–379.PubMedCrossRefGoogle Scholar
  63. 63.
    Pack S., Kirshner L.S., Pak E., Carney J.A., Zhuang Z., Stratakis C.A. Pituitary tumors in patients with the “complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas” (Carney complex): evidence for progression from somatomammotroph hyperplasia to adenoma. J. Clin. Endocrinol. Metab. 2000, 85: 3860–3865.PubMedGoogle Scholar
  64. 64.
    Premkumar A., Stratakis C.A., Shawker T.H., Papanicolaou D.A., Chrousos G.P. Testicular ultrasound in Carney complex. J. Clin. Ultrasound 1997, 25: 211–214.PubMedCrossRefGoogle Scholar
  65. 65.
    Stratakis C.A., Papageorgiou T., Premkumar A., Kirschner L.S., Taymans S.E., Pack S., Zhuang Z., Oelkers W.H., Carney J.A. Ovarian cysts in patients with Carney complex: clinical and genetic studies and evidence for predisposition to cancer. J. Clin. Endocrinol. Metab. 2000, 85: 4359–4366.PubMedCrossRefGoogle Scholar
  66. 66.
    Carney J.A. Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am. J. Surg. Pathol. 1990, 14: 206–222.PubMedCrossRefGoogle Scholar
  67. 67.
    Carney J.A., Toorkey B.C. Ductal adenoma of the breast with tubular features. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Am. J. Surg. Pathol. 1991, 15: 722–731.PubMedCrossRefGoogle Scholar
  68. 68.
    Carney J.A., Stratakis C.A. Ductal adenoma of the breast. Am. J. Surg. Pathol. 1996, 20: 1154–1155.PubMedCrossRefGoogle Scholar
  69. 69.
    Stratakis C.A., Courcoutsakis N., Abati A., Filie A., Doppman J.L., Carney J.A., Shawker T.H. Thyroid gland abnormalities in patients with the “syndrome of spotty skin pigmentation, myxomas, and endocrine overactivity” (Carney complex). J. Clin. Endocrinol. Metab. 1997, 82: 2037–2043.PubMedCrossRefGoogle Scholar
  70. 70.
    Stratakis C.A., Carney J.A., Lin J.-P., Papanicolaou D.A., Karl M., Kastner D.L., Pras E., Chrousos G.P. Carney Complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J. Clin. Invest. 1996, 97: 699–705.PubMedCentralPubMedCrossRefGoogle Scholar
  71. 71.
    Casey M., Mah C., Merliss A.D., Kirschner L.S., Taymans S.E., Denio A.E., Korf B., Irvine A.D., Hughes A., Carney J.A., Stratakis C.A., Basson C.T. Identification of a novel genetic locus for familial cardiac myxomas and Carney Complex. Circulation 1998, 98: 2560–2566.PubMedCrossRefGoogle Scholar
  72. 72.
    Stratakis C.A., Pras E., Lin J.-P., Kastner D.L., Carney J.A., Chrousos G.P. Carney complex, a multiple endocrine neoplasia and familial lentiginosis syndrome: clinical analysis and linkage to the D2S123 locus (chromosome 2p16). Am. J. Hum. Genet. 1995, 57: A54.Google Scholar
  73. 73.
    Dewald G.W., Dahl R.J., Spurbeck J.L., Carney J.A., Gordon H. Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas. Mayo Clin. Proc. 1987, 62: 558–567.PubMedCrossRefGoogle Scholar
  74. 74.
    Dijkhuizen T., van der Derg E., Molenaar W.M., Meuzelaar J.J., de Jong B. Cytogenetics of a case of cardiac myxoma. Cancer Genet. Cytogenet. 1992, 63: 73–75.PubMedCrossRefGoogle Scholar
  75. 75.
    Richkind K.E., Wason D., Vidaillet H.J. Cardiac myxoma characterized by clonal telomeric association. Genes Chrom. Cancer 1994, 9: 68–71.PubMedCrossRefGoogle Scholar
  76. 76.
    Stratakis C.A., Jenkins R.B., Pras E., Mitsiades C.S., Raff S.B., Stalboerger P., Tsigos C., Carney J.A., Chrousos G.P. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex). J. Clin. Endocrinol. Metab. 1996, 81: 3607–3614.PubMedGoogle Scholar
  77. 77.
    Takai S., Iwama T., Tonomura A. Chromosome instability in cultured skin fibroblasts from patients with familial polyposis coli and Peutz-Jeghers syndrome. Jpn. J. Cancer Res. 1986, 77: 759–766.PubMedGoogle Scholar
  78. 78.
    Griffin C.A., Lazar S., Hamilton S.R., Giardello F.M., Long P., Krush A.J. Cytogenetic analysis of intestinal polyps in polyposis syndromes: comparison with sporadic colorectal adenomas. Cancer Genet. Cytogenet. 1993, 67: 14–20.PubMedCrossRefGoogle Scholar
  79. 79.
    Richard F., Muleris M., Dutrillaux B. Chromosome instability in lymphocytes from patients affected by or genetically predisposed to colorectal cancer. Cancer Genet. Cytogenet. 1994, 73: 23–32.PubMedCrossRefGoogle Scholar
  80. 80.
    DeMarco L., Stratakis C.A., Boson W.L., Yakbovitz O., Carson E., Adrade L.M., Chrousos G.P., Nordenskjold M., Friedman E. Sporadic cardiac myxomas and tumors from patients with Carney complex are not associated with activating mutations of the Gsα gene. Hum. Genet. 1996, 98: 185–188.PubMedCrossRefGoogle Scholar
  81. 81.
    Basson C.T., MacRae C.A., Korf B., Merliss A. Genetic heterogeneity of familial atrial myxoma syndromes (Carney Complex). Am. J. Cardiol. 1997, 79: 994–995.PubMedCrossRefGoogle Scholar
  82. 82.
    Taymans S.E., Macrae C.A., Casey M., Merliss A., Lin J.-P., Rocchi M., Kirschner L.S., Basson C.T., Stratakis C.A. A refined genetic, radiation hybrid, and physical map of the Carney complex (CNC) locus on chromosome 2p16; evidence for genetic heterogeneity in the syndrome. Am. J. Hum. Genet. 1997, 61: A84.Google Scholar
  83. 83.
    Scott J.D. Cyclic nucleotide-dependent protein kinases. Pharmac. Ther. 1991, 50: 123–145.CrossRefGoogle Scholar
  84. 84.
    Kirschner L.S., Sandrini F., Monbo J., Carney J.A., Stratakis C.A. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum. Mol. Genet. 2000, 9: 3037–3046.PubMedCrossRefGoogle Scholar
  85. 85.
    Taymans S.E., Kirschner L.S., Pack S., Ping Z., Stratakis C.A. YAC-BAC contig of the Carney complex (CNC) critical region on 2p16 and copy number gain of 2p16 in CNC tumors: evidence for a novel oncogene? Am. J. Hum. Genet. 1999, 65: A326.Google Scholar
  86. 86.
    Stratakis C.A., Kirschner L.S., Taymans S.E., Tomlinson I.P.M., Marsh D.J., Torpy D.J., Giatzakis C., Eccles D.M., Theaker J., Houlston R.S., Blouin J.-L., Antonarakis S.E., Basson C.T., Eng C., Carney J.A. Carney complex, Peutz-Jeghers syndrome, Cowden disease, and Bannayan-Zonana syndrome share cutaneous and endocrine manifestations, but not genetic loci. J. Clin. Endocrinol. Metab. 1998, 83: 2972–2976.PubMedCrossRefGoogle Scholar
  87. 87.
    Peutz J.L.A. Very remarkable case of familial polyposis of mucous membrane of intestinal tract and nasopharynx accompanied by peculiar pigmentation of skin and mucous membrane. Nederl. Maandschr. Geneesk. 1921, 10: 134–146.Google Scholar
  88. 88.
    Jeghers H., McKusick V.A., Katz K.H. Generalised intestinal polyposis and melanin spots of the oral mucosa, lips and digits. N. Engl. J. Med. 1949, 241: 993–1005; 1031–1036.PubMedCrossRefGoogle Scholar
  89. 89.
    Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell. Mol. Life Sci. 1999, 55: 735–750.PubMedCrossRefGoogle Scholar
  90. 90.
    Hemminki A., Tomlinson I., Markie D., Järvinen H., Sistonen P., Bjorkqvist A.-M., Knuutila S., Salovaara R., Bodmer W., Shibata D., de la Chapelle A., Aaltonen L.A. Localisation of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridisation and targeted linkage analysis. Nat. Genet. 1997, 15: 87–90.PubMedCrossRefGoogle Scholar
  91. 91.
    Boardman L.A., Thibodeau S.N., Schaid D.J., Lindor N.M., McDonnell S.K., Burgart L.J., Ahlquist D.A., Podratz K.C., Pittelkow M., Hartmann L.C. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann. Intern. Med. 1998, 128: 896–899.PubMedCrossRefGoogle Scholar
  92. 92.
    Westerman A.M., Wilson J.H.P. Peutz-Jeghers syndrome: Risks of a hereditary condition. A clinical review. Scand. J. Gastroenterol. 1999, 230: 64–70.CrossRefGoogle Scholar
  93. 93.
    Giardello F.M., Welsh S.B., Hamilton S.R., Offerhaus G.J.A., Gittelsohn A.M., Booker S.V. Increased risk of cancer in the Peutz-Jeghers syndrome. N. Engl. J. Med. 1987, 316: 1511–1514.CrossRefGoogle Scholar
  94. 94.
    Hizawa K., Iida M., Matsumoto T., Kohrogi N., Kinoshita H., Yao T. Cancer in Peutz-Jeghers syndrome. Cancer 1993, 72: 2777–2781.PubMedCrossRefGoogle Scholar
  95. 95.
    Foley T.R., McGarrity T.J., Abt A.B. Peutz-Jeghers syndrome: a clinicopathologic survey of the “Harrisburg family” with a 49-year follow up. Gastroenterology 1988, 95: 1535–1540.PubMedGoogle Scholar
  96. 96.
    Rustgi A.K. Hereditary gastrointestinal polyposis and non-polyposis syndromes. N. Engl. J. Med. 1994, 331: 1694–1702.PubMedCrossRefGoogle Scholar
  97. 100.
    Spigelman A.D., Murday V., Phillips R.K.S. Cancer and Peutz-Jeghers syndrome. Gut 1989, 30: 1588–1590.PubMedCentralPubMedCrossRefGoogle Scholar
  98. 101.
    Pathomvanich A., Koch C., Stratakis C.A. Thyroid abnormalities in Peutz-Jeghers syndrome: Report of new observation and review of the literature. J. Endocr. Genet. 1999, 1: 47–49.Google Scholar
  99. 102.
    Young R.H., Scully R.E. Mucinous ovarian tumors associated with mucinous adenocarcinomas of the cervix: clinicopathologic analysis of 16 cases. Int. J. Gynecol. Pathol. 1988, 7: 99–111.PubMedCrossRefGoogle Scholar
  100. 103.
    Young R.H., Welch W.R., Dickersin G.E., Scully R.E. Ovarian sex stromal tumor with annular tubules; review of 74 cases including 27 with Peutz-Jeghers syndrome and 4 with adenoma malignum of the cervix. Cancer 1982, 50: 1384–1402.PubMedCrossRefGoogle Scholar
  101. 104.
    Young S., Gooneratne S., Straus F.H., Zeller W.P., Bulun S.E., Rosenthal I.M. Feminizing Sertoli cell tumors in boys with Peutz-Jeghers syndrome. Am. J. Surg. Pathol. 1995, 19: 50–58.PubMedCrossRefGoogle Scholar
  102. 105.
    Markie D., Huson S., Maher E., Davies A., Tomlison I., Bodmer W.F. A pericentric inversion of chromosome 6 in a patient with Peutz-Jeghers syndrome and the use of FISH to localize the breakpoints on a genetic map. Hum. Genet. 1996, 98: 125–128.PubMedCrossRefGoogle Scholar
  103. 106.
    Bali D., Gourley I.S., McGarrity T.J., Spencer C.A., Howard L., Frazier M.L., Amos C. Peutz-Jeghers syndrome maps to chromosome 1p. Am. J. Hum. Genet. 1995, 57: A186.Google Scholar
  104. 107.
    Tomlinson I.P.M., Olschwang S., Abelovitch D., Nakamura Y., Bodmer W.F., Thomas G., Markie D. Testing candidate loci on chromosomes 1 and 6 for genetic linkage to Peutz-Jegher’s disease. Ann. Hum. Genet. 1996, 60: 377–384.PubMedCrossRefGoogle Scholar
  105. 108.
    Olschwang S., Markie D., Seal S., Neale K., Phillips R., Cottrell S., Ellis I., Hodgson S., Zauber P., Spigelman A., Iwama T., Loff S., McKeown C., Marchese C., Sampson J., Davies S., Talbot I., Wyke J., Thomas G., Bodmer W., Hemminki A., Avizienyte E., de la Chapelle A., Aaltonen L., Stratton M., Houlston R., Tomlinson I. Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J. Med. Genet. 1998, 35: 42–44.PubMedCentralPubMedCrossRefGoogle Scholar
  106. 109.
    Mehenni H., Blouin J.-L., Radhakrishna U., Bhardwaj S.S., Bhardwaj K., Dixit V.B., Richards K.F., Bermejo-Fenoll A., Leal A.S., Raval R.C., Antonarakis S.E. Peutz-Jeghers syndrome: Confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4. Am. J. Hum. Genet. 1997, 61: 1327–1334.PubMedCentralPubMedCrossRefGoogle Scholar
  107. 110.
    Westerman A.M., Entius M.M., Boor P.P.C., Koole R., de Baar E., Offerhaus G.J.A., Lubinski J., Lindhout D., Halley D.J.J., de Rooij F.W.M., Wilson J.H.P. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum. Mutat. 1999, 13: 476–481.PubMedCrossRefGoogle Scholar
  108. 111.
    Wang Z.-J., Churchman M., Avizienyte E., McKeown C., Davies S., Evans D.G.R., Ferguson A., Ellis I., Xu W.-H., Yan Z.-Y., Aaltonen L.A., Tomlinson I.P.M. Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients. J. Med. Genet. 1999, 36: 365–368.PubMedCentralPubMedGoogle Scholar
  109. 112.
    Resta N., Simone C., Mareni C., Montera M., Gentile M., Susca F., Gristina R., Pozzi S., Bertario L., Bufo P., Carlomagno N., Ingrosso M., Rossini F.P., Tenconi R., Guanti G. STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer Res. 1998, 58: 4799–4801.PubMedGoogle Scholar
  110. 113.
    Jiang C.-Y., Esufali S., Berk T., Gallinger S., Cohen Z., Tobi M., Redston M., Bapat B. STK11/LKB1 germline mutations are not identified in most Peutz-Jeghers syndrome patients. Clin. Genet. 1999, 56: 136–141.PubMedCrossRefGoogle Scholar
  111. 114.
    Ylikorkala A., Avizienyte E., Tomlinson I.P.M., Tiainen M., Roth S., Loukola A., Hemminki A., Johansson M., Sistonen P., Markie D., Neale K., Phillips R., Zauber P., Twama T., Sampson J., Järvinen H., Mäkelä T.P., Aaltonen L.A. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum. Mol. Genet. 1999, 8: 45–51.PubMedCrossRefGoogle Scholar
  112. 115.
    Boardman L.A., Couch F.J., Burgart L.J., Schwartz D., Berry R., McDonnell S.K., Schaid D.J., Hartmann L.C., Schroeder J.J., Stratakis C.A., Thibodeau S.N. Genetic heterogeneity in Peutz-Jeghers syndrome. Hum. Mutat. 2000, 16: 23–30.PubMedCrossRefGoogle Scholar
  113. 116.
    Su J.-Y., Erikson E., Maller J.L. Cloning and characterisation of a novel serine/threonine protein kinase expressed in early Xenopus embryos. J. Biol. Chem. 1996, 271: 14430–14437.PubMedCrossRefGoogle Scholar
  114. 117.
    Smith D.P., Spicer J., Smith A., Swift S., Ashworth A. The mouse Peutz-Jeghers syndrome gene Lkb1 encodes a nuclear protein kinase. Hum. Mol. Genet. 1999, 8: 1479–1485.PubMedCrossRefGoogle Scholar
  115. 118.
    Mehenni H., Gehrig C., Nezu J., Oku A., Shimane M., Rossier C., Guex N., Blouin J.-L., Scott H.S., Antonarakis S.E. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am. J. Hum. Genet. 1998, 63: 1641–1650.PubMedCentralPubMedCrossRefGoogle Scholar
  116. 119.
    Nelen M.R., Padberg G.W., Peeters E.A.J., Lin A.Y., van den Helm B., Frants R.R., Coulon V., Goldstein A.M., van Reen M.M.M., Easton D.F., Eeles R.A., Hodgson S., Mulvihill J.J., Murday V.A., Tucker M.A., Mariman E.C.M., Starink T.M., Ponder B.A.J., Ropers H.H., Kremer H., Longy M., Eng C. Localization of the gene for Cowden disease to chromosome 10q22–23. Nat. Genet. 1996, 13: 114–116.PubMedCrossRefGoogle Scholar
  117. 120.
    Eng C. Genetics of Cowden syndrome: Through the looking glass of oncology. Int. J. Oncol. 1998, 12: 701–710.PubMedGoogle Scholar
  118. 121.
    Nelen M.R., van Staveren W.C.G., Peeters E.A.J., Hassel M.B., Gorlin R.J., Hamm H., Lindboe C.F., Fryns J.-P., Sijmons R.H., Woods D.G., Mariman E.C.M., Padberg G.W., Kremer H. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet. 1997, 6: 1383–1387.PubMedCrossRefGoogle Scholar
  119. 122.
    Marsh D.J., Kum J.B., Lunetta K.L., Bennett M.J., Gorlin R.J., Ahmed S.F., Bodurtha J., Crowe C., Curtis M.A., Dasouki M., Dunn T., Feit H., Geraghty M.T., Graham J.M., Hodgson S.V., Hunter A., Korf B.R., Manchester D., Miesfeldt S., Murday V.A., Nathanson K.L., Parisi M., Pober B., Romano C., Tolmie J.L., Trembath R., Winter R.M., Zackai E.H., Zori R.T., Weng L.-P., Dahia P.L.M., Eng C. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet. 1999, 8: 1461–1472.PubMedCrossRefGoogle Scholar
  120. 123.
    Longy M., Coulon V., Duboue B., David A., Larregue M., Eng C., Amati P., Kraimps J.-L., Bottani A., Lacombe D., Bonneau D. Mutations of PTEN in patients with Bannayan-Riley-Ruvalacaba phenotype. J. Med. Genet. 1998, 35: 886–889.PubMedCentralPubMedCrossRefGoogle Scholar
  121. 124.
    Linehan W.M., Lerman M.I., Zbar B. Identification of the von Hippel-Lindau (VHL) gene. JAMA 1995, 273: 564–570.PubMedCrossRefGoogle Scholar
  122. 125.
    Richards F.M., Webster A.R., McMahon R., Woodward E.R., Rose S., Maher E.R. Molecular genetic analysis of von Hippel-Lindau disease. J. Intern. Med. 1998, 243: 527–533.PubMedCrossRefGoogle Scholar
  123. 126.
    Bar M., Friedman E., Jakobovitz O., Leibowitz G., Lerer I., Abeliovich D., Gross D.J. Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel-Lindau and RET genes. Clin. Endocrinol. (Oxf.) 1997, 47: 707–712.CrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2001

Authors and Affiliations

  1. 1.Unit on Genetics and Endocrinology, Developmental Endocrinology Branch, National Institute of Child Health and Human DevelopmentNational Institutes of HealthBethesdaUSA

Personalised recommendations